2022年
- Identification of serum microRNAs as potential diagnostic biomarkers for detecting precancerous lesions of gastric cancer
Otsu H, Nambara S, Hu Q, Hisamatsu Y, Toshima T, Takeishi K, Yonemura Y, Masuda T, Oki E, Mimori K.
Ann Gastroenterol Surg. 2022 Aug 10;7(1):63-70. doi: 10.1002/ags3.12610. eCollection 2023 Jan.PMID: 36643367
- A case of malignant phyllodes tumor that responded to pazopanib and developed pneumothorax.
Ohmura H, Masuda T, Mimori K, Baba E, Horiuchi T.
Int Cancer Conf J. 2022 Aug 7;12(1):31-35. doi: 10.1007/s13691-022-00572-9. eCollection 2023 Jan.PMID: 36605841
- Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma.
Sugimachi K, Araki H, Saito H, Masuda T, Miura F, Inoue K, Shimagaki T, Mano Y, Iguchi T, Morita M, Toh Y, Yoshizumi T, Ito T, Mimori K.
JGH Open. 2022 Oct 30;6(12):854-863. doi: 10.1002/jgh3.12833. eCollection 2022 Dec.PMID: 36514506
- Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer.
Mochizuki K, Kudo SE, Kato K, Kudo K, Ogawa Y, Kouyama Y, Takashina Y, Ichimasa K, Tobo T, Toshima T, Hisamatsu Y, Yonemura Y, Masuda T, Miyachi H, Ishida F, Nemoto T, Mimori K.
PLoS One. 2022 Oct 20;17(10):e0273566. doi: 10.1371/journal.pone.0273566. eCollection 2022.PMID: 36264865
- PRKRIP1, A Splicing Complex Factor, Is a Marker of Poor Prognosis in Colorectal Cancer.
Ozato Y, Masuda T, Kobayashi Y, Takao S, Hisamatu Y, Toshima T, Yonemura Y, Uemura M, Eguchi H, Doki Y, Mori M, Mimori K.
Anticancer Res. 2022 Oct;42(10):4701-4706. doi: 10.21873/anticanres.15974.PMID: 36192001
- Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers.
Soyama H, Nishio M, Otani J, Sakuma T, Takao S, Hara S, Masuda T, Mimori K, Toyokuni S, Lydon JP, Nakao K, Nishina H, Fukumoto T, Maehama T, Suzuki A.
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2123134119. doi: 10.1073/pnas.2123134119. Epub 2022 Jul 11.PMID: 35858357
- Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements.
Ueo H, Minoura I, Ueo H, Gamachi A, Kai Y, Kubota Y, Doi T, Yamaguchi M, Yamashita T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Masuda T, Urano Y, Mori M, Mimori K.
Sci Rep. 2022 May 20;12(1):8520. doi: 10.1038/s41598-022-12614-6.PMID: 35595810
- Artificial intelligence-assisted drug repurposing via “chemical-induced gene expression ranking”.
Masuda T, Mimori K.
Patterns (N Y). 2022 Apr 8;3(4):100470. doi: 10.1016/j.patter.2022.100470. eCollection 2022 Apr 8.PMID: 35465226
- Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin.
Shimizu D, Taniue K, Matsui Y, Haeno H, Araki H, Miura F, Fukunaga M, Shiraishi K, Miyamoto Y, Tsukamoto S, Komine A, Kobayashi Y, Kitagawa A, Yoshikawa Y, Sato K, Saito T, Ito S, Masuda T, Niida A, Suzuki M, Baba H, Ito T, Akimitsu N, Kodera Y, Mimori K.
Cancer Gene Ther. 2022 May;29(5):428-436. doi: 10.1038/s41417-021-00401-w. Epub 2021 Nov 8.PMID: 34744163
- Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma.
Takahashi J, Masuda T, Kitagawa A, Tobo T, Nakano Y, Abe T, Ando Y, Kosai K, Kobayashi Y, Matsumoto Y, Yoshizumi T, Mori M, Mimori K.
COncology. 2022;100(2):101-113. doi: 10.1159/000520582. Epub 2021 Nov 1.PMID: 34724663
- GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein.
Koike K, Masuda T, Sato K, Fujii A, Wakiyama H, Tobo T, Takahashi J, Motomura Y, Nakano T, Saito H, Matsumoto Y, Otsu H, Takeishi K, Yonemura Y, Mimori K, Nakagawa T.
Cancer Sci. 2022 Jan;113(1):156-169. doi: 10.1111/cas.15174. Epub 2021 Nov 10.PMID: 34704338